Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice

被引:5
作者
Bonet, Marta [1 ]
Garcia, Virginia [1 ]
Farre, Nuria [2 ]
Algara, Manel [3 ]
Farrus, Blanca [4 ]
Fernandez, Jaume [5 ]
Reyes, Victoria [6 ]
Eraso, Arancha [7 ]
Alvarez, Ana [8 ]
Jose Cambra, Maria [9 ]
Pedro, Agusti [10 ]
Vayreda, Jordi [11 ]
Lemansky, Claire [12 ]
Izar, Francoise [13 ]
Arenas, Meritxell [14 ]
机构
[1] Hosp Arnau Vilanova, Dept Radiat Oncol, Av Alcalde Rovira Roure 80, Lleida 25198, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Radiat Oncol, Barcelona, Spain
[3] Parc Salut Mar, Dept Radiat Oncol, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Radiat Oncol, Barcelona, Spain
[5] Hosp Quiron, Dept Radiat Oncol, Barcelona, Spain
[6] Hosp Valle De Hebron, Dept Radiat Oncol, Barcelona, Spain
[7] Hosp Duran & Reynals, Dept Radiat Oncol, Inst Catala Oncol, Barcelona, Spain
[8] Hosp Badalona Germans Trias & Pujol, Dept Radiat Oncol, Inst Catala Oncol, Badalona, Spain
[9] Hosp Gen Cataluna, Inst Oncol Valles, Sant Cugat Del Valles, Spain
[10] Hosp Plato, Dept Radiat Oncol, Barcelona, Spain
[11] Hosp Josep Trueta, Dept Radiat Oncol, Inst Catala Oncol, Girona, Spain
[12] Univ Montpellier, Inst Cancerol Montpellier Val dAurelle, Dept Radiat Oncol, Montpellier, France
[13] Inst Univ Canc Toulouse, Dept Radiat Oncol, Toulouse, France
[14] Hosp Univ St Joan de Reus, Dept Radiat Oncol, Tarragona, Spain
关键词
Bone metastases; Oligometastases; Breast cancer; Radiation therapy; SBRT; STEREOTACTIC BODY RADIOTHERAPY; PROGNOSIS; ACHIEVE;
D O I
10.1016/j.rpor.2019.12.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The role of radiation therapy (RT) for patients with bone-only metastatic (BOM) breast cancer has not been investigated sufficiently. The aim of this survey was to evaluate current clinical practice in treating breast cancer patients with BOM in Radiation Therapy Departments in Catalonia and Occitania within the scope of the GOCO group. Materials and methods: An electronic questionnaire was completed by experienced radiation oncologists from fourteen RT centers. The items surveyed the professional experience, therapeutic approach, technique, dose stereotactic body RT (SBRT) availability. Results: All Radiation Oncology Departments (ROD) in Catalonia (12) and Occitania (2) responded to the survey. Eleven (78.5%) of the RODs advise RT for BOM as initial treatment in the oligometastatic setting. RT to asymptomatic bone oligometastases is more often restricted for "risky lesions". The most inconsistent approaches were the treatment for asymptomatic lesions, when to treat bone metastases with respect to systemic treatment (ST) and the indication for RT after a complete response to ST. Conclusion: While BOM breast cancer patients have a relatively good prognosis, there is a lack of consistency in their approach with RT. This can be explained by the absence of evidence-based guidelines and an incomplete availability of SBRT. (C) 2019 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 50 条
[11]   Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis [J].
Kundaktepe, Berrin Papila ;
Sozer, Volkan ;
Kundaktepe, Fatih Orkun ;
Durmus, Sinem ;
Papila, Cigdem ;
Uzun, Hafize ;
Simsek, Gonul ;
Gelisgen, Remise .
MEDICINA-LITHUANIA, 2021, 57 (09)
[12]   Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis [J].
Park, Soyeon ;
Yoon, Joon-Kee ;
Lee, Su Jin ;
Kang, Seok Yun ;
Yim, Hyunee ;
An, Young-Sil .
MEDICINE, 2017, 96 (50)
[13]   Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid [J].
Yanaea, Masashi ;
Fujimoto, Shinichiro ;
Tane, Kaori ;
Tanioka, Maki ;
Fujiwara, Kimiko ;
Tsubaki, Masanobu ;
Yamazoe, Yuzuru ;
Morishima, Yoshiyuki ;
Chiba, Yasutaka ;
Takao, Shintaro ;
Komoike, Yoshifumi ;
Tsurutani, Junji ;
Nakagawa, Kazuhiko ;
Nishida, Shozo .
JOURNAL OF BONE ONCOLOGY, 2017, 8 :18-22
[14]   Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients [J].
Harries, M. ;
Taylor, A. ;
Holmberg, L. ;
Agbaje, O. ;
Garmo, H. ;
Kabilan, S. ;
Purushotham, A. .
CANCER EPIDEMIOLOGY, 2014, 38 (04) :427-434
[15]   Stereotactic Ablative Radiotherapy for Bone-Only Oligometastatic Breast Cancer: On a Quest to Find the Optimum Cohort [J].
Yilmaz, M. T. ;
Gultekin, M. ;
Sari, S. Yuce ;
Kumru, T. ;
Kivanc, H. ;
Ozyigit, G. ;
Yildiz, F. .
CLINICAL ONCOLOGY, 2025, 37
[16]   Pharmacotherapy of bone metastases in breast cancer patients [J].
Petrut, Bianca ;
Simmons, Christine ;
Broom, Reuben ;
Trinkaus, Mateya ;
Clemons, Mark .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (06) :937-945
[17]   Treatment of bone metastases in breast cancer patients [J].
Pawlak, Wojciech Z. ;
Wawrocka-Pawlak, Marlena .
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (08) :401-407
[18]   Evolving Practice Pattern of Palliative Radiation Therapy for Bone Metastases from Lung Cancer in Australia [J].
Ong, W. L. ;
Ball, D. L. ;
Milne, R. L. ;
Foroudi, F. ;
Millar, J. L. .
CLINICAL ONCOLOGY, 2021, 33 (12) :E530-E539
[19]   The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer [J].
Shyam Tanguturi ;
Laura E. G. Warren .
Current Oncology Reports, 2019, 21
[20]   The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer [J].
Tanguturi, Shyam ;
Warren, Laura E. G. .
CURRENT ONCOLOGY REPORTS, 2019, 21 (06)